The only report of an Atrx knockout (KO), established in a GEMM of pancreatic ductal adenocarcinoma (PDAC), states that Atrx has a potential role in increasing susceptibility to pancreatic inflammation and tumourigenesis [31]. Here, ATRX is linked to pancreatic ductal adenocarcinoma.